IMMUNITY TO EPSTEIN-BARR VIRUS IN CYCLOSPORIN A-TREATED RENAL ALLOGRAFT RECIPIENTS
- 26 June 1982
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 319 (8287) , 1469-1470
- https://doi.org/10.1016/s0140-6736(82)92479-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Studies on long‐term T‐cell‐mediated immunity to epstein‐barr virus in immunosuppressed renal allograft recipientsInternational Journal of Cancer, 1981
- CYCLOSPORIN A IMMUNOSUPPRESSION AND EPSTEIN-BARR ANTIBODYThe Lancet, 1981
- LONG-TERM T-CELL-MEDIATED IMMUNITY TO EPSTEIN-BARR VIRUS IN RENAL-ALLOGRAFT RECIPIENTS RECEIVING CYCLOSPORIN AThe Lancet, 1981
- CYCLOSPORIN A AND EPSTEIN-BARR VIRUSThe Lancet, 1980
- EPSTEIN BARR VIRUS NUCLEAR ANTIGEN POSITIVE LYMPHOMA AFTER CYCLOSPORIN A TREATMENT IN PATIENT WITH RENAL ALLOGRAFTThe Lancet, 1980
- CYCLOSPORIN A IMMUNOSUPPRESSION, EPSTEIN-BARR ANTIBODY, AND LYMPHOMAThe Lancet, 1980
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. I. Complete regression of virus‐induced transformation in cultures of seropositive donor leukocytesInternational Journal of Cancer, 1978
- Diagnosis of Treatable Wilson's DiseaseNew England Journal of Medicine, 1978
- Immunofluorescence in Cells Derived from Burkitt's LymphomaJournal of Bacteriology, 1966